Typhidot is NOT a reliable diagnostic test for typhoid fever and should not be used
Serologic tests, including Typhidot, should not be used to diagnose enteric fever 1. The most authoritative and recent guideline—the 2017 IDSA Clinical Practice Guidelines—provides a strong recommendation with moderate-quality evidence explicitly stating that serologic tests lack adequate performance characteristics for typhoid diagnosis 1.
Why Typhidot Fails as a Diagnostic Tool
Guideline-Based Evidence Against Serologic Testing
The IDSA guidelines are unequivocal: blood culture remains the gold standard for diagnosing enteric fever, with bone marrow culture being even more sensitive (particularly valuable if antibiotics have already been started) 1. The guidelines specifically recommend against serologic testing due to poor performance characteristics 1.
Multiple UK guidelines from 2009 reinforce this position, noting that while newer rapid serological tests like Typhidot, Typhidot-M, and similar IgM-detecting assays have been developed, they have shown mixed results and are not recommended 2.
Research Evidence Confirms Poor Performance
The most comprehensive systematic review and meta-analysis examining Typhidot variants across 22 studies found:
- Average sensitivity: 84% (but drops to 78% when indeterminate results are properly accounted for)
- Average specificity: 79% (drops to 77% with proper accounting) 3
These numbers translate to unacceptable clinical performance. In a population where 30% have typhoid fever (300 of 1000 patients), Typhidot would:
- Miss 66 patients who actually have typhoid fever
- Falsely diagnose 161 patients who don't have the disease 3
Recent 2024 data from Ghana showed even worse performance:
- Sensitivity: 35% compared to culture
- Specificity: 45% compared to culture 4
This means Typhidot would miss nearly two-thirds of actual cases while falsely diagnosing over half of those without disease—completely unacceptable for clinical decision-making.
What TO Use Instead
First-Line Diagnostic Approach
Blood culture (2-3 sets of 20 mL each in adults):
Bone marrow culture (if feasible):
- Higher sensitivity than blood culture
- Particularly valuable if antibiotics already given 1
Stool, duodenal fluid, and urine cultures:
- Become positive after the first week
- Stool culture sensitivity: 35-65%
- Urine culture sensitivity: 0-58% 2
Culture-independent diagnostics (CIDTs):
- Panel-based multiplex molecular diagnostics from stool and blood
- Nucleic acid amplification tests (NAATs) useful in research settings but lack sensitivity for blood detection 1
Critical Pitfalls to Avoid
- Never rely on Widal test: Even worse performance than Typhidot, with poor sensitivity and specificity 2
- Don't wait for culture results to treat: If clinical suspicion is high and patient unstable, start empiric therapy immediately 2
- Ensure adequate blood volume: Low bacteremia magnitude (0.3 CFU/mL) requires larger volumes for detection 1
- Consider resistance patterns: Over 70% of S. typhi from Asia show fluoroquinolone resistance; ceftriaxone is preferred first-line 2
When to Suspect Enteric Fever
Consider typhoid in febrile patients with:
- Travel history to endemic areas (South/Southeast Asia, Central/South America, Africa)
- Consumed food prepared by recent travelers from endemic areas
- Laboratory exposure to S. Typhi or S. Paratyphi 1
- Note: Diarrhea is UNCOMMON in enteric fever despite GI portal of entry 1
Bottom Line
Typhidot and other serologic rapid tests have consistently demonstrated inadequate sensitivity and specificity across multiple studies and geographic regions. Their use leads to missed diagnoses in patients who need treatment and unnecessary antibiotic exposure in those without disease. Blood culture before antibiotics remains the cornerstone of diagnosis, supplemented by bone marrow culture when feasible and stool/urine cultures after the first week of illness 1.